Laser photocoagulation for macular soft drusen. Updated results.
OBJECTIVE
To update the results of a study on the disappearance of macular soft drusen after laser treatment in the natural evolution of age-related macular degeneration.


METHODS
A total of 46 patients with confluent soft drusen and pigmentary changes were studied prospectively. Group 1 was composed of 30 patients with bilateral drusen; the authors randomly assigned one eye of each patient for treatment and the fellow eye for the control. In 16 patients a choroidal neovascular membrane was present in one eye, and treatment was applied to the fellow eye (group 2). Argon green laser treatment was applied directly to the soft drusen in the temporal macula.


RESULTS
All treated drusen disappeared in a mean of 3.5 months after treatment, and untreated drusen disappeared in all but three patients in an average of 8.5 months. After an average period of 3 years, only one control eye and none of the treated eyes in group 1 developed a choroidal neovascular membrane (P = 0.500). In group 2, neovascularization occurred in 18% of the patients. The initial improvement in Snellen acuity after subfoveal drusen disappearance diminished as a consequence of cataract progression.


CONCLUSIONS
Although no definitive conclusions should be made because of the small number of patients studied, results seem to show that this treatment does not reduce the risk of choroidal neovascularization in the treated eye of patients with a history of exudative disease in the fellow eye. It may be effective in patients with high-risk bilateral soft drusen, that is, in less advanced stages of the disease.
Figueroa
M S
MS
Department of Ophthalmology, Rámon y Cajal Hospital, Madrid, Spain.
Regueras
A
A
Bertrand
J
J
Aparicio
M J
MJ
Manrique
M G
MG
D000368:Aged; D002829:Choroid / Q000098:blood supply; D005451:Fluorescein Angiography; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D017075:Laser Coagulation / Q000009:adverse effects; D008268:Macular Degeneration / Q000503:physiopathology / Q000601:surgery*; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology; D011446:Prospective Studies; D015593:Retinal Drusen / Q000503:physiopathology / Q000601:surgery*; D012307:Risk Factors; D016896:Treatment Outcome; D014792:Visual Acuity / Q000502:physiology